Donald J. Elmer
Fundador en Pacific Horizon Ventures LLC .
Perfil
Donald J.
Elmer is the founder of Pacific Horizon Ventures LLC, which was founded in 1993.
He is currently the Chairman of Koronis Pharmaceuticals, Inc. since 2014 and the Chairman of Illumigen Biosciences, Inc. He has previously worked as a Director at ViaCyte, Inc. and as a Principal at Pricewaterhouse & Co. Mr. Elmer has a graduate degree from the University of Pennsylvania and an undergraduate degree from Western Washington University.
Cargos activos de Donald J. Elmer
| Empresas | Cargo | Inicio |
|---|---|---|
Pacific Horizon Ventures LLC
 Pacific Horizon Ventures LLC Investment ManagersFinance Pacific Horizon Ventures LLC (Pacific Horizon Ventures) is a venture capital firm founded in 1993 by Donald J. Elmer. The firm is headquartered in Seattle. | Fundador | 29/09/2009 |
Koronis Pharmaceuticals, Inc.
 Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Presidente | - |
Illumigen Biosciences, Inc.
 Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA | Presidente | - |
Antiguos cargos conocidos de Donald J. Elmer.
| Empresas | Cargo | Fin |
|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | 29/01/2019 |
| Pricewaterhouse & Co. | Corporate Officer/Principal | - |
Formación de Donald J. Elmer.
| University of Pennsylvania | Graduate Degree |
| Western Washington University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
| Pricewaterhouse & Co. | Commercial Services |
Pacific Horizon Ventures LLC
Pacific Horizon Ventures LLC Investment ManagersFinance Pacific Horizon Ventures LLC (Pacific Horizon Ventures) is a venture capital firm founded in 1993 by Donald J. Elmer. The firm is headquartered in Seattle. | Finance |
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Health Technology |
Illumigen Biosciences, Inc.
Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA | Health Technology |
- Bolsa de valores
- Insiders
- Donald J. Elmer
